A Study of the Pharmacokinetics of Black Cohosh

Phase 1TerminatedNCT00068185

National Center for Complementary and Integrative Health (NCCIH)12 enrolled

Overview

Black cohosh is a natural supplement that has been used to treat and prevent menopausal symptoms. Remifemin is a standardized form of black cohosh. The purpose of this study is to determine the levels of components of black cohosh obtained in the blood of healthy women taking Remifemin.

As per Brief Summary

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Hot Flashes

Interventions

Black cohoshDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * No prior diagnosis of cancer other than non-melanoma skin cancer or carcinoma in-situ of the cervix * No current prescription medication use * Negative urine pregnancy test OR greater than age 50 with no menses for at least one year OR documented status post hysterectomy * Competent to understand and sign informed consent

Locations (1)

Duke University Medical Center

Durham, North Carolina, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.